North America Intravascular Stents Market Size & Outlook
North America intravascular stents market, 2018-2030 (US$M)
Related Markets
North America intravascular stents market highlights
- The North America intravascular stents market generated a revenue of USD 5,960.8 million in 2023.
- The market is expected to grow at a CAGR of 7.7% from 2024 to 2030.
- In terms of segment, coronary stents was the largest revenue generating product in 2023.
- Peripheral Stents is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 5,960.8 million |
| Market revenue in 2030 | USD 10,014.7 million |
| Growth rate | 7.7% (CAGR from 2023 to 2030) |
| Largest segment | Coronary stents |
| Fastest growing segment | Peripheral Stents |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Coronary Stents, Peripheral Stents, Neurovascular Stents |
| Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Terumo Corp, Abbott Laboratories, BIOTRONIK, LifeTech Scientific Corp, iVascular, Stryker Corp, Cook Medical, MicroPort Scientific Corp, Stentys, Hellman & Friedman, B. Braun Medical |
Other key industry trends
- In terms of revenue, North America region accounted for 44.9% of the global intravascular stents market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,130.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Intravascular Stents Market Scope
Intravascular Stents Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America intravascular stents market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravascular stents market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 78.23% in 2023. Horizon Databook has segmented the North America intravascular stents market based on coronary stents, peripheral stents, neurovascular stents covering the revenue growth of each sub-segment from 2018 to 2030.
- North America Intravascular Stents Product Outlook (Revenue, USD Million, 2018-2030)
- Coronary Stents
- Peripheral Stents
- Iliac Artery Stents
- Femoral Artery Stents
- Carotid Artery Stents
- Renal Artery Stents
- Other Peripheral Stents
- Neurovascular Stents
- Intracranial Stents
- Flow Diverters
- North America Intravascular Stents Type Outlook (Revenue, USD Million, 2018-2030)
- Drug Eluting Stents (DES)
- Bare Metal Stents (BMS)
- Bioabsorbable Stents
- North America Intravascular Stents Mode of Delivery Outlook (Revenue, USD Million, 2018-2030)
- Self-expanding Stents
- Balloon-expandable Stents
- North America Intravascular Stents End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals & Cardiac Centers
- Ambulatory Surgical Centers
- Others
Reasons to subscribe to North America intravascular stents market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America intravascular stents market databook
-
Our clientele includes a mix of intravascular stents market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America intravascular stents market , including forecasts for subscribers. This continent databook contains high-level insights into North America intravascular stents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America intravascular stents market size, by country, 2018-2030 (US$M)
North America Intravascular Stents Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
